CooperCompanies Reports Q2 Revenue, Updates 2026 Full-Year Guidance

SAN RAMON, Calif.—CooperCompanies (Nasdaq: COO), a leading global medical device company, yesterday reported financial results for its second quarter for the period ending April 30, 2026, and updated its full-year guidance. Second-quarter 2026 revenue totaled $1.082 billion, reflecting an 8 percent overall increase, and 5 percent growth organically as well as in constant currency compared with the same period last year, the company said. It reported a gross margin of 68 percent, which was similar to last year’s second quarter. The company reported a net loss of $77.9 million for the quarter, as compared with a net income of $87.7 million for the same period the prior year.